The Food and Drug Administration’s controversial vaccine chief, Dr. Vinay Prasad, is once again leaving the agency. FDA Commissioner Marty Makary announced the departure to staff in an email ...

A review of declassified CIA files has reportedly revealed how a biological outbreak which impacts tens of thousands every ...

A gene borrowed from the naked mole rat, an animal famous for extraordinary longevity and disease resistance, helped mice live a little longer and stay healthier, pointing to a surprising biological ...

GLP toxicology studies ongoing for CMP-002, with initiation of global Phase 1/2 clinical trial in SYNGAP1 patients expected as early as 2H 2026 ...

The modern-day ironing board was invented by Sarah Boone, who took the original clunky design and transformed it into a sleek ...

Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced that the latest long-term survival analysis data from the China pivotal registrational Phase II study ...

Under the settlement, Genevant Sciences and Arbutus Biopharma will grant Moderna a non-exclusive license to their lipid nanoparticle technology for mRNA delivery in infectious disease vaccines. If ...

Researchers have found that targeted delivery of messenger RNA (mRNA) can restore sperm production and fertility in genetically infertile male mice. The findings, published in Stem Cell Reports, ...

Moderna has managed to eke out some temporary wins, paving the way for the homegrown biotech to focus on its next moves.

A resurrected ancient enzyme is helping scientists test how reliably Earth’s oldest rocks record signs of life.

Moderna will pay up to $2.25B to settle a patent lawsuit over lipid nanoparticle technology used in its COVID-19 vaccine.

Moderna Inc.’s settlement to end a lawsuit over technology used in its Covid-19 vaccine caps its potential exposure at $2.25 ...